Annual Retained Earnings
-$655.77 M
-$136.67 M-26.33%
31 December 2023
Summary:
Century Therapeutics annual retained earnings is currently -$655.77 million, with the most recent change of -$136.67 million (-26.33%) on 31 December 2023. During the last 3 years, it has fallen by -$363.43 million (-124.32%). IPSC annual retained earnings is now -174.65% below its all-time high of -$238.77 million, reached on 31 December 2019.IPSC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$746.27 M
-$31.23 M-4.37%
30 September 2024
Summary:
Century Therapeutics quarterly retained earnings is currently -$746.27 million, with the most recent change of -$31.23 million (-4.37%) on 30 September 2024. Over the past year, it has dropped by -$129.89 million (-21.07%). IPSC quarterly retained earnings is now -155.27% below its all-time high of -$292.34 million, reached on 31 December 2020.IPSC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.3% | -21.1% |
| 3 y3 years | -124.3% | -107.3% |
| 5 y5 years | - | - |
IPSC Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -124.3% | at low | -107.3% | at low |
| 5 y | 5 years | -174.7% | at low | -155.3% | at low |
| alltime | all time | -174.7% | at low | -155.3% | at low |
Century Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$746.27 M(+4.4%) |
| June 2024 | - | -$715.04 M(+4.6%) |
| Mar 2024 | - | -$683.83 M(+4.3%) |
| Dec 2023 | -$655.77 M(+26.3%) | -$655.77 M(+6.4%) |
| Sept 2023 | - | -$616.37 M(+5.6%) |
| June 2023 | - | -$583.65 M(+6.0%) |
| Mar 2023 | - | -$550.36 M(+6.0%) |
| Dec 2022 | -$519.10 M | -$519.10 M(+6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$487.42 M(+6.7%) |
| June 2022 | - | -$456.67 M(+7.3%) |
| Mar 2022 | - | -$425.68 M(+9.7%) |
| Dec 2021 | -$388.17 M(+32.8%) | -$388.17 M(+7.8%) |
| Sept 2021 | - | -$359.97 M(+7.8%) |
| June 2021 | - | -$333.96 M(+7.5%) |
| Mar 2021 | - | -$310.69 M(+6.3%) |
| Dec 2020 | -$292.34 M(+22.4%) | -$292.34 M |
| Dec 2019 | -$238.77 M | - |
FAQ
- What is Century Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Century Therapeutics?
- What is Century Therapeutics annual retained earnings year-on-year change?
- What is Century Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Century Therapeutics?
- What is Century Therapeutics quarterly retained earnings year-on-year change?
What is Century Therapeutics annual retained earnings?
The current annual retained earnings of IPSC is -$655.77 M
What is the all time high annual retained earnings for Century Therapeutics?
Century Therapeutics all-time high annual retained earnings is -$238.77 M
What is Century Therapeutics annual retained earnings year-on-year change?
Over the past year, IPSC annual retained earnings has changed by -$136.67 M (-26.33%)
What is Century Therapeutics quarterly retained earnings?
The current quarterly retained earnings of IPSC is -$746.27 M
What is the all time high quarterly retained earnings for Century Therapeutics?
Century Therapeutics all-time high quarterly retained earnings is -$292.34 M
What is Century Therapeutics quarterly retained earnings year-on-year change?
Over the past year, IPSC quarterly retained earnings has changed by -$129.89 M (-21.07%)